CClinicalTrials.gg
RecruitingNCT07490184Updated Aug 4, 2026

Cardiac Clearance vs G60 Hip Frailty Index

An observational study in Cardiac Disease, sponsored by Methodist Health System. Recruiting at 1 site in United States. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-08-04.

Sponsored by Methodist Health System · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
100
Ages
60 Years and older
Sex
All
01

Study summary

The primary objective of this study is to establish a data repository that will be permissive of quality improvement studies/observations specific to postoperative mortality outcomes for geriatric patients with orthopedic injuries based on Orthopedic Hip Frailty Score and preoperative cardiac clearance predictors.

Read the detailed description

It is typically a result of advanced aging. Among geriatric patients suffering from hip fractures, frailty is common and is associated with an increased risk of postoperative complications and morbidity with hip fracture surgery. Developed by the Swedish National Quality Registry, the Orthopedic Hip Frailty Score aims to predict short-term postoperative mortality in geriatric patients with hip fractures in order to improve patient outcomes and better allocate resources.

02

Conditions studied

  • Cardiac Disease

Browse trials for

03

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Among geriatric patients suffering from hip fractures, frailty is common and is associated with an increased risk of postoperative complications and morbidity with hip fracture surgery.

Inclusion criteria

≥60 years old Included in the Methodist Dallas Medical Center Trauma Registry Documented orthopedic injury with surgical management

Exclusion criteria

Exclusion Criteria:

\<60 years old Prisoners, pregnant persons, or other protected populations

04

Study design

Observational model
Other
Time perspective
Other
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Total Number and Description of Study Sites/Total Number of Subjects Projected

    This study will include all geriatric trauma patients at Methodist Dallas Medical Center who meet registry inclusion and have an operative orthopedic injury. Enrollment will terminate once five years of data are captured: January 2018 through December 2023.

    Other: Medical/Phenotype Data Collection Procedures & Data to be Collected

Interventions

  • OtherMedical/Phenotype Data Collection Procedures & Data to be Collected

    The Methodist Dallas Medical Center Trauma Registry will be queried for demographic information, diagnosis codes, admission dates, traumatic injury characteristics, surgical procedures, comorbidities, inpatient outcomes, complications, consultations, discharge location, and mortality.

05

What researchers measure

Primary outcomes

  1. Total Number of Study Sites

    This study will include all geriatric trauma patients at Methodist Dallas Medical Center who meet registry inclusion and have an operative orthopedic injury. Enrollment will terminate once five years of data are captured: January 2018 through December 2023.

    Time frame: 5 years

06

Study locations

1 of 1 sites recruiting
  • Clinical Research Institute at Methodist Health System
    Dallas, Texas 75203, United States
    Recruiting
07

References and documents

Individual participant data

Plan to share: Yes — All information will be blinded in compliance with Good Clinical Practice. The investigator will make all possible efforts to ensure compliance with all policies regarding sharing of protected health information or research information. Only de-identified protected health information will be shared in relevant research mediums.

Supporting information: Study protocol

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07490184
Lead sponsor
Methodist Health System
Responsible party
Sponsor
First posted
Mar 24, 2026
Start date
Jan 30, 2024
Primary completion
Feb 2027 (estimated)
Completion
Feb 2028 (estimated)
Last update
Aug 4, 2026

Study contacts

Crystee Cooper, DHEd
Contact
ClinicalResearch@mhd.com
214-947-1280
Kavya Mankulangara
Contact
ClinicalResearch@mhd.com
214-947-4604
Jennifer Burris, MD
principal investigator · Methodist Health System

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion